A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants
Status:
RECRUITING
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
A phase 1, randomized, double blind, placebo controlled drug-drug interaction, pharmacokinetics and safety study of cefiderocol in combination with xeruborbactam in healthy adult participants
Phase:
PHASE1
Details
Lead Sponsor:
Qpex Biopharma, Inc.
Collaborators:
Biomedical Advanced Research and Development Authority Shionogi Inc.